English
Français
Português
Русский
Español
Uzbek
Myanmar
A medicine manufacturer Vietnam international partners rely on is one whose commercial reach extends consistently across its domestic market. Vinphaco recently completed its H2.2026 Mid-Year Review and OTC Sales Training for its Central and Southern Vietnam representative teams — a structured program covering market intelligence, selling skills development, and product knowledge reinforcement, designed to accelerate commercial performance across Vietnam’s retail pharmacy network in the second half of 2026. Explore Vinphaco’s Vietnamese operations at vinphaco.vn.
1. OTC Market Intelligence — Reading the Opportunity Landscape
The program opened with a comprehensive OTC market review covering consumer trends in non-prescription pharmaceutical purchasing, pharmacy network dynamics across Central and Southern Vietnam, and growth opportunities within Vinphaco’s priority product categories for H2.2026.
Vietnam’s OTC pharmaceutical market is in an active growth phase — driven by expanding self-care adoption, increasing pharmacy density in secondary cities and provincial towns, and rising consumer awareness of pharmaceutical quality standards. For a medicine manufacturer Vietnam supplying both domestic retail and international export markets, the depth of domestic OTC market penetration is a direct indicator of brand credibility and distribution infrastructure strength.
2. Skills Development — Three Core Competencies for Pharmacy Channel Excellence
Through practical training sessions and peer experience sharing, the OTC representative teams developed capability across three interconnected commercial skill areas.
Pharmacy selling skills — creating measurable value for pharmacy partners in every visit, from product recommendation support to display optimisation and inventory management guidance. Customer relationship management — building the consistent, trust-based partnerships with pharmacy owners that generate sustainable long-term sales performance rather than transactional volume. Territory development — expanding coverage across underserved pharmacy points, identifying growth opportunities within existing territories, and optimising visit route efficiency across diverse Central and Southern Vietnam market environments.
3. Product Knowledge — The Foundation of Pharmacy Partner Trust
OTC pharmaceutical representation depends on the credibility that comes from genuine product expertise. The training dedicated substantial time to consolidating representative knowledge across Vinphaco’s OTC active ingredient portfolio — mechanism of action, competitive differentiation, and standardised selling messages that translate pharmacological value into clear, practical recommendations for pharmacy partners.
For international buyers, the product knowledge standard maintained by Vinphaco’s domestic commercial team reflects the same depth of technical understanding that informs the company’s manufacturing decisions — a consistency between commercial and production expertise that characterises serious pharmaceutical organisations.
4. Commercial Breadth as a Supply Partnership Signal
The H2.2026 OTC training follows Vinphaco’s Northern ETC team training in Nghe An earlier in 2026 — together representing a sustained, nationwide investment in commercial capability development across both hospital and retail pharmacy channels simultaneously.
For international pharmaceutical partners, this commercial infrastructure breadth — ETC hospital networks in the north, OTC pharmacy networks across central and southern regions — signals a domestic market integration depth that directly supports the manufacturing investment cycle. A medicine manufacturer Vietnam whose products are actively sold, promoted, and trusted across Vietnam’s full commercial pharmacy landscape is one whose production capacity is continuously validated by real-world market demand.
With clear targets, sharpened skills, and unified team commitment, Vinphaco’s OTC teams across Central and Southern Vietnam are ready to accelerate — delivering on the company’s H2.2026 ambition to break through and raise the bar.
To discuss pharmaceutical supply partnerships, contract manufacturing, or export distribution arrangements: vinphaco.net/contact | vinphaco.vn
